- Home
- INOD vs CDTX Comparison
INOD vs CDTX Comparison
Compare INOD & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- CDTX
- Stock Information
- Founded
- INOD 1988
- CDTX 2012
- Country
- INOD United States
- CDTX United States
- Employees
- INOD N/A
- CDTX N/A
- Industry
- INOD EDP Services
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INOD Technology
- CDTX Health Care
- Exchange
- INOD Nasdaq
- CDTX Nasdaq
- Market Cap
- INOD 1.2B
- CDTX 980.1M
- IPO Year
- INOD 1993
- CDTX 2015
- Fundamental
- Price
- INOD $50.00
- CDTX $46.35
- Analyst Decision
- INOD Strong Buy
- CDTX Strong Buy
- Analyst Count
- INOD 4
- CDTX 11
- Target Price
- INOD $57.50
- CDTX $52.11
- AVG Volume (30 Days)
- INOD 2.9M
- CDTX 1.3M
- Earning Date
- INOD 08-07-2025
- CDTX 08-12-2025
- Dividend Yield
- INOD N/A
- CDTX N/A
- EPS Growth
- INOD 1293.88
- CDTX N/A
- EPS
- INOD 1.08
- CDTX N/A
- Revenue
- INOD $202,301,000.00
- CDTX $302,000.00
- Revenue This Year
- INOD $44.28
- CDTX N/A
- Revenue Next Year
- INOD $22.64
- CDTX N/A
- P/E Ratio
- INOD $46.58
- CDTX N/A
- Revenue Growth
- INOD 114.21
- CDTX N/A
- 52 Week Low
- INOD $13.02
- CDTX $10.14
- 52 Week High
- INOD $71.00
- CDTX $56.83
- Technical
- Relative Strength Index (RSI)
- INOD 57.80
- CDTX 77.98
- Support Level
- INOD $46.15
- CDTX $44.46
- Resistance Level
- INOD $52.60
- CDTX $50.48
- Average True Range (ATR)
- INOD 3.95
- CDTX 4.26
- MACD
- INOD 0.06
- CDTX 1.62
- Stochastic Oscillator
- INOD 81.64
- CDTX 78.05
About INOD Innodata Inc.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.